Reviewed by Eleonora Teplinsky, MD, Head of Breast Medical Oncology at Valley Health System in Paramus, New Jersey, Clinical Assistant Professor at Icahn School of Medicine at Mount Sinai in New York ...

Applies to most patients with one or two positive sentinel lymph nodes ...

The largest randomized trial of its kind to date found noninferior survival and better arm morbidity among patients with breast cancer who did not undergo completion axillary lymph node dissection.

Please provide your email address to receive an email when new articles are posted on . Skipping sentinel lymph node biopsy can be considered for node-negative, HR-positive, HER2-negative early breast ...

Omitting completion axillary lymph node dissection does not increase risk for death for patients with clinically node-negative breast cancer, but it does significantly improve arm distress.Data from ...

Dear Reader: A biopsy is a diagnostic medical procedure to collect cells from the body, then examine them under a microscope for abnormalities. This can reveal the presence of a disease or condition.

Phase 3 lidERA evaluates daily oral SERD giredestrant in ER+/HER2- early disease, including subgroup analyses by age and menopausal status after a reported 30% risk reduction. Primary ASCENT-04 data ...

Adding tumor-bed biopsy to trimodality imaging after neoadjuvant chemotherapy did not reliably predict pathological complete response for breast cancer patients. The negative predictive value of the ...

A Jacksonville veteran says she was diagnosed with stage 3 breast cancer months after doctors at the Jacksonville VA ...

Whether you are under 40 or over 80, breast cancer knows no age limits. Don’t stop getting mammograms just because “they” say ...

Here’s how they picked themselves back up after a devastating diagnosis.

A 42-year-old woman presented with an atypical enlarging breast mass over the course, which initially raised suspicion of a serious condition but resolved spontaneously. Initial physical examination ...